Events - Spark Newswire

1 minute read

Earlier Reported, BriaCell CEO Discusses Clinical Results Of Its Breast Cancer Immunotherapy Treatment In An Audio Interview With SmallCapVoice.com

Today, 12:22 PM

SmallCapVoice.com Inc. ("SCV") announces the availability of a new audio interview with Dr. Bill Williams, CEO of BriaCell Therapeutics Corp.

BCTX

2 minute read

Recession Is ‘Price We Pay’ For Misreading Inflationary Pressures, Says Singapore Senior Minister

By Bhavik Nair

Today, 12:22 PM

Singapore’s Senior Minister Tharman Shanmugaratnam said on Tuesday that recession is the “price we pay” for misreading inflationary pressures and the ongoing spell of weakness in the global economy was due to central banks worldwide over-betting

BND

2 minute read

Warren Buffett Disclosing $4.1B Stake Leads To 8% Spike In Apple Supplier’s Stock

By Navdeep Yadav

Today, 12:22 PM

Apple Inc. (NASDAQ:AAPL) supplier Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) shares jumped nearly 8% on Tuesday after billionaire investor Warren Buffett‘s Berkshire Hathaway

AAPL

2 minute read

KalVista Pharmaceuticals Presents Patient-Focused Data At American College of Allergy, Asthma & Immunology 2022 Meeting

By Benzinga Newsdesk

Today, 12:22 PM

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today presented two posters

KALV

2 minute read

Worried About A Housing Shortage? These 2 Equity REITs Paying Large Dividends Could Benefit Investors

By Robert Kuczmarski

Today, 12:22 PM

The five-year average dividend yield for various real estate investment trusts is amongst the lowest for manufactured homes at 2.6%, SP Global reported. Manufactured homes cost only two-thirds the rate of existing site-built homes and less than half the cost of new site-built homes, per Deloitte.

ELS

3 minute read

Dose Escalation Data From TranscendIT-101, Ascendis Pharma’s Phase 1/2 Trial Of TransCon TLR7/8 Agonist In Patients With Advanced Solid Tumors, Presented At SITC 2022

By Benzinga Newsdesk

Today, 12:22 PM

- Early signs of clinical activity were observed in patients receiving TransCon TLR7/8 Agonist as monotherapy or in combination with pembrolizumab; abscopal effect observed with monotherapy - With a single

ASND

2 minute read

Zillow: Homebuying Changed In 2022 – Will The Metaverse Upend The Process Even More?

By Robert Kuczmarski

Today, 12:22 PM

Between the Covid-19 pandemic and recent macroeconomic headwinds, homebuyers’ preferences are changing.

GOOGL

1 minute read

VBI Vaccines Announces Presentation Of Data From Ongoing Phase 2a Study Of VBI-1901 At The 2022 Society For Neuro-Oncology Annual Meeting

By Benzinga Newsdesk

Today, 12:22 PM

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that its abstract highlighting data from the ongoing

VBIV

3 minute read

Nurix Announces Initial NX-1607 Phase 1 Data Presented At The 37th Annual Meeting Of The Society For Immunotherapy Of Cancer Demonstrating Targeted CBL-B Inhibition In Patients With Advanced Malignancies

By Benzinga Newsdesk

Today, 12:22 PM

Biomarker results are a positive demonstration of target engagement for this first-in-class CBL-B inhibitor Biomarker levels achieved with NX-1607 treatment correspond to levels associated with potent anti-tumor

NRIX

2 minute read

Hey, Ray Dalio! You’re Invited To Benzinga’s December 2022 NYC Crypto And Fintech Events. See You There?

By Justin Roberti

Today, 12:22 PM

Benzinga cordially invites Ray Dalio to attend its next event, The Future of Crypto summit, on December 7-8, 2022, at NYC's Pier Sixty. No RSVP is required. Just show up, and we'll cover your stay, too! The event will feature:

BTC